Table 3.
Appropriateness of medications as defined by PEACE consensus panel
| Always appropriate | ||
| Antidiarrheals | Antiepileptic drugs | Expectorants |
| Laxatives | Anxiolytics | Lubricating eye drops |
| Antiemetics | Narcotic analgesics | Pressure ulcer products |
| Inhaled bronchodilators | Nonnarcotic analgesics | Lidoderm |
| Sometimes appropriate | ||
| Proton pump inhibitors | Antidepressants | Insulin |
| Histamine-2 receptor blockers | Tricyclic antidepressants | Antihistamines |
| Beta-blockers | Antibacterials | Decongestants |
| Calcium channel blockers | Antivirals | Electrolytes |
| Diuretics | Antiparasitic agents | Nutritional supplements |
| Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers | Antifungal creams | Antiglaucoma drops |
| Nitroglycerin | Oral hypoglycaemics | Anti-inflammatory eye drops |
| Mucolytics | Thyroid hormones | Capsaicin |
| Inhaled corticosteroids | Antithyroid medications | Allopurinol |
| Antipsychotics | Corticosteroids | Colchicine |
| Rarely appropriate | ||
| Alpha blockers | Antiandrogens | Appetite stimulants |
| Digoxin | Bisphosphonates | Bladder relaxants |
| Clonidine | Mineralocorticoids | Tamsulosin |
| Antiarrhythmics | Heparin and low molecular-weight heparins | Antispasmodics |
| Hydralazine | Warfarin | |
| Never appropriate | ||
| Lipid-lowering medications | Memantine | Cytotoxic chemotherapy |
| Antiplatelet agents, excluding aspirin | Antiestrogens | Hormone antagonists |
| Leukotriene receptor antagonists | Sex hormones | Immunomodulators |
| Acetylcholinesterase inhibitors | ||
| No consensus | ||
| Aspirin | Meclizine | Bladder stimulants |
| Sedatives and hypnotics | Vitamins | Iron |
| Central nervous system stimulants | Mineral supplements | Finasteride |
| Muscle relaxants | Calcitonin | Red blood cell colony stimulating factors |
Sourced from Holmes et al. (2008) [16]